BNET Industries
Novartis AG is in the Pharma Industry
Latest News and Analysis
What's Ailing the Pharmaceutical Sector?
Marc Courtenay submits: Lou Basenese, The Associate Editor of the Oxford Club is a respected friend and colleague. With his permission, I want to share what he recently wrote on the pharmaceuticals drug companies. He has some very interesting observations and recommendations that we should all take to heart. His...
Daiichi Sankyo, Other Big Pharmas, Going Generic
Eben Tessari submits: The generic drug business is growing twice as fast as branded medicines so it is no wonder that J&J JNJ, Novartis NVS with the purchase of Hexal and Eon to form Sandoz and now Daiichi Sankyo are interested. Daiichi Sankyo announced Wednesday that they will...
J&J Signs Potential Deal With Astex
LONDON (Reuters UK) - Astex Therapeutics has signed a cancer drug research deal with Johnson & Johnson JNJ potentially worth more than $500 million (253 million pounds) in milestone payments, it said on Monday. The privately owned biotech company will receive upfront payments, cash and...
Analyst Notes: Lilly Gets A Lift, Pfizer Goes Pfft
Mike Huckman submits: Despite at least a couple of analysts coming out with relatively bullish post-ASCO research notes on Pfizer's PFE oncology drug pipeline, PFE shares have fallen to yet another new low intra-day and have crossed another threshold. But Eli Lilly LLY is the biggest dollar and percentage...
Novartis Buys Protez For Super Anti-Biotic Defense
Eben Tessari submits: Image via Wikipedia by Eben Tessari
Novartis AG Q3 2007 Earnings Call Transcript
Novartis AG Q3 2007 Earnings Call Transcript
Novartis Q2 2007 Earnings Call Transcript
Novartis Q2 2007 Earnings Call Transcript
Integrating Global Processes and Enhancing R & D Investment Efficiency With SAP Software
The Swiss-based Novartis group ranks fifth in the world pharmaceuticals market. Novartis Pharma K.K., launched a project in 2002 to implement SAP R/3 software available today in mySAP ERP and SAP Business Information Warehouse SAP BW, and cut over to the new system in January 2004. The project's foundation was...
Common Enterprise Repository For R&D Documents Promises 144% Return on Investment
This article is about the Novartis, The merges of Swiss firms Sandoz and Ciba. It defines the requirements of the merger. Before the merger, employees at Sandoz had relied on a combination of paper files, local servers, PCs, and a VMS system to store their research documentation. The...
Globalization, Minima Moralia, And The Responsibilities Of Multinational Companies
Globalization also involves the idea of the "global village" in relation to communication, information, networking, and monitoring. It is a matter of enlightened self-interest for companies to behave in a socially and environmentally acceptable way wherever they operate, not just so as to avoid damaging their reputation, but also to...
The Pharmaceutical Industry And Social Responsibility: Idealism Without Illusion And Realism Without Resignation
Sustained corporate success depends, in addition to all other factors that successful managers are so well aware of, on the courage and imagination to respond to the needs and welfare of relevant takeholders. The power of partnerships comes from their participatory and multistakeholder nature. The multistakeholder aspect allows for an...
Post-Merger Integration: How Novartis Became No. 1
Article says that once the deal is done, the hard work begins of integrating people, processes and systems, on a global basis. It amplifies that in a time of rapid globalization and consolidation, mergers have become almost an inevitable part of doing business, an essential element of corporate survival. But,...
Case Study: Novartis Solar Heating
Novartis Consumer Health is part of the Swiss multinational pharmaceutical company formed after the merger of Sandoz Pharmaceuticals and Ciba Geigy. Because the Rowville manufacturing unit of Novartis is a food manufacturing plant, the hot water used for cleaning process equipment must be at least 75?C, in order to comply...
Novartis Goes Lean
Under increasing pressure to reduce costs, and improve the quality of their products, more pharmaceutical companies are adopting techniques well established in other industries--Lean manufacturing, Six Sigma, process teams--to drug making. Many of the techniques, first developed for discrete manufacturing, can't simply be "dropped in" to the more complex pharmaceutical...
Additional Resources
Business Digest
AstraZeneca wins Seroquel case *The Anglo-Swedish pharmaceutical group AstraZeneca received a boost yesterday when an American court upheld its patent over the $4bn- (2bn) a- year schizophrenia and bipolar blockbuster Seroquel. The New Jersey District Court awarded AstraZeneca summary judgment in the face of...
Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
Jury verdict in Montgomery County Circuit Court awards $33 million in compensatory damages Jury decides in favor of Novartis and rejects claims for punitive damages NPC maintains it reported true and accurate prices and will file appeal EAST HANOVER, N.J., July 1 /PRNewswire/...
Noven Names Anthony Venditti Vice President - Marketing & Sales
MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced the appointment of senior pharmaceutical executive Anthony Venditti as its Vice President - Marketing & Sales, effective immediately. In this role, Venditti will lead all aspects of the marketing and sales functions at Noven Therapeutics (the company's specialty pharmaceutical business unit) and...
Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone
Phase I Study to Explore the Effects of EligenR Delivery Technology on Healthy Postmenopausal Women CEDAR KNOLLS, N.J., June 30 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. announced today that Novartis Pharma AG has launched a Phase I study in postmenopausal women to determine the safety and tolerability...
A New Citeline Analysis Provides Valuable Clues to Health of Drug Companies
Report in Good Clinical Practice Journal GCPj Finds That Novartis Leads the Pack for Ongoing Trials in Autoimmune, Cardiovascular, and Metabolic Diseases Sanofi-aventis Takes the Top Rank for Ongoing Oncology Trials NEW YORK, June 30 /PRNewswire/ -- In a new Expert Analysis article published in...
Rules-Based Medicine Commercializes New Toxicity Biomarker Panel in Conjunction with FDA, EMEA, C-Path and PSTC
For Use in Pre-Clinical Trials to Evaluate Early Renal Toxicity, New Rat Kidney MAP Will Aid in Faster Development of Safer Drugs AUSTIN, Texas -- Rules-Based Medicine, Inc. RBM, the leading multiplexed biomarker testing laboratory for the life sciences industry, announced today that it has commercialized a new...
- Next »
- page 1 of 249
- « Previous
Sort byClose
View Related Content by Tag Close
Novartis AG Company Info
NAICS Code
Pharmaceutical Preparation Manufacturing: 325412
